The Pharmacy Times® Allergy Resource Center is a comprehensive resource for clinical news and expert insights on issues related to conditions that cause the immune system to react abnormally to a foreign substance, including seasonal allergies, food allergies, drug allergies, and contact dermatitis.
July 16th 2025
The biosimilar showed similar efficacy, pharmacokinetics, pharmacodynamics, safety, quality of life, and immunogenicity in patients with chronic spontaneous urticaria (CSU).
According to Ocular Therapeutix, Dextenza is now the first FDA-approved, physician-administered intracanalicular insert capable of delivering a preservative-free drug for the treatment of ocular itching associated with allergic conjunctivitis with a single administration for up to 30 days.
Read More
FDA Approves Treatment for Pollen-Induced Allergic Rhinitis in Children, Adolescents
April 20th 2021The FDA has expanded its approval of short ragweed pollen allergen extract (Ragwitek; ALK) to include treatment for children and adolescents, starting at age 5 years, with short ragweed pollen-induced allergic rhinitis.
Read More
Review Confirms Nasal Hygiene Measures Are Effective to Protect Against COVID-19
March 23rd 2021Intranasal administration of virucidal and antiviral therapies may provide added clinical benefit by decreasing viral activity in the nasal pathway, preventing COVID-19 transmission and managing disease severity.
Read More
Allergens That Cause Contact Dermatitis Found in Masks That Prevent COVID-19
November 14th 2020The patient was prescribed prednisone for the rash when he was seen by emergency department physicians, and a follow up telehealth visit with the hospital’s allergy clinic was done when the patient’s symptoms were not relieved.
Read More